KinCon biolabs
- Biotech or pharma, therapeutic R&D
- Other R&D services
KinCon biolabs provides a patented target-protein engagement technology to enable the discovery, characterization, validation and selection of new drugs. We create genetically encoded reporters allowing the systematic monitoring of cellular interactions between drug candidates and target proteins.
KinCon biolabs is actively seeking collaborations and partnerships to support biotech and pharmaceutical companies in discovery and selection of drug candidates against hard-to-target proteins.